Literature DB >> 16451220

Regulation of MT melatonin receptor expression in the foetal rat pituitary.

J D Johnston1, P Klosen, P Barrett, D G Hazlerigg.   

Abstract

During development, melatonin receptors are transiently expressed in multiple neuroendocrine tissues, suggesting a novel role for melatonin in developmental physiology. The best characterised model of melatonin signalling during development is the pars distalis of the rat pituitary. However, although many studies have characterised the postnatal decline of melatonin receptors in the rat pars distalis, the mechanism(s) that time the developmental onset of receptor expression during embryogenesis are unknown. Analysis of these mechanisms may yield important information regarding the putative role of melatonin in neuroendocrine development. Here, we report the expression of MT(1) melatonin receptor mRNA in the rat pituitary from embryonic day 15.5 (e15.5). Prior to e15.5, the homeodomain transcription factor Msx-1, an inhibitor of cellular differentiation, is widely expressed throughout the pituitary. In transient transfection experiments, Msx-1 potently inhibited pituitary homeobox-1 (Pitx-1)-induced MT(1) promoter activity and therefore may represent a key inhibitor of MT(1) expression in early pituitary development. During late embryogenesis, MT(1) mRNA was expressed in both the ventral and dorsal pituitary. Analysis of a 1.5-kb fragment of the rat MT(1) promoter revealed four putative cis-elements for the POU domain factor Pit-1, which is associated with mid-dorsal cell lineages. Although Pit-1 induced a strong, dose-dependent stimulation of MT(1) promoter activity in vitro, dual-labelled in situ hybridisation revealed no colocalisation of MT(1) and Pit-1 mRNAs in vivo at e19.5. By contrast, all MT(1) positive cells colocalised with alphaGSU and most with betaTSH mRNA. Our data therefore implicate the decline of Msx-1 expression as a key event that times the onset of melatonin receptor expression to the differentiation of endocrine cells types in the developing pituitary gland, and suggest that the melatonin-sensitive cells in the embryonic pituitary are primarily Pit-1-independent thyrotrophs in the rostral pituitary, with a secondary population of pars distalis gonadotrophs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16451220     DOI: 10.1111/j.1365-2826.2005.01389.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  6 in total

1.  Msx1 homeodomain protein represses the αGSU and GnRH receptor genes during gonadotrope development.

Authors:  Huimin Xie; Brian D Cherrington; Jason D Meadows; Emily A Witham; Pamela L Mellon
Journal:  Mol Endocrinol       Date:  2013-01-31

Review 2.  Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new?

Authors:  R Jockers; P Maurice; J A Boutin; P Delagrange
Journal:  Br J Pharmacol       Date:  2008-05-19       Impact factor: 8.739

3.  Expression of MSX1 in human normal pituitaries and pituitary adenomas.

Authors:  Yoshihito Mizokami; Noboru Egashira; Susumu Takekoshi; Johbu Itoh; Yoshiko Itoh; Robert Yoshiyuki Osamura; Mitsunori Matsumae
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

Review 4.  Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives.

Authors:  Stephen G Grant; Melissa A Melan; Jean J Latimer; Paula A Witt-Enderby
Journal:  Expert Rev Mol Med       Date:  2009-02-05       Impact factor: 5.600

5.  Regulation of pituitary MT1 melatonin receptor expression by gonadotrophin-releasing hormone (GnRH) and early growth response factor-1 (Egr-1): in vivo and in vitro studies.

Authors:  Sung-Eun Bae; Ian K Wright; Cathy Wyse; Nathalie Samson-Desvignes; Pascale Le Blanc; Serge Laroche; David G Hazlerigg; Jonathan D Johnston
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

Review 6.  Clocks for all seasons: unwinding the roles and mechanisms of circadian and interval timers in the hypothalamus and pituitary.

Authors:  Shona Wood; Andrew Loudon
Journal:  J Endocrinol       Date:  2014-06-02       Impact factor: 4.286

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.